Klinische Studie

Early Feasibility Study of 3930M Defibrillation Lead Implantation Via the Middle Cardiac Vein in Patients With Tricuspid Valve Regurgitation

NCT: NCT07811609 · NOT_YET_RECRUITING

NCT-IDNCT07811609

Medizinische Daten: StatusNOT_YET_RECRUITING

SponsorMinneapolis Heart Institute Foundation (OTHER)

First posted2026-09-10

Last updated2026-09-10

Kurzzusammenfassung

Prospective, single center, early feasibility study designed to evaluate the initial safety and device performance of the Medtronic 3930M Lead when implanted via the Middle Cardiac Vein in patients with Tricuspid Valve Regurgitation

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.